Indonesian Court Strikes Down Patent Evergreening, a Tactic That Keeps Drug Prices High

Indonesia's Constitutional Court ruled that a two-year-old amendment allowing 'patent evergreening'—a tactic where drugmakers file additional patents with minor tweaks to keep prices high and forestall competition—was unconstitutional, restoring the original prohibition after patient and advocacy groups brought the case.